TNO Quality of Life, Department Toxicology and Applied Pharmacology, Zeist, The Netherlands.
Toxicology. 2010 Feb 28;269(1):73-80. doi: 10.1016/j.tox.2010.01.008. Epub 2010 Jan 21.
Previously, the contact allergen dinitrochlorobenzene (DNCB) was identified as a sensitizer by inhalation in BALB/c mice; in addition, DNCB induced a lymphocytic infiltrate in the larynx of dermally sensitized Th1-prone Wistar rats upon a single inhalation challenge. In the present study, repeated inhalation exposures to DNCB were investigated using the same protocol as the single-challenge study: female Wistar rats were dermally sensitized with DNCB and subsequently challenged by inhalation exposure to 7 or 15 mg/m(3) DNCB twice a week for 4 weeks. Allergy-related apnoeic breathing was not observed. DNCB-specific IgG antibodies were found in the serum and--predominantly lymphocytic--inflammations were found in the nasal tissues and larynx. Similar effects were observed in animals repeatedly exposed by inhalation without previous dermal contact, indicating sensitization by inhalation. The inflammation may be the upper respiratory tract analogue of hypersensitivity pneumonitis/allergic alveolitis. Possible progression of the airway inflammation upon long-term exposure should be investigated to support or dismiss discrimination between contact and respiratory allergens in relation to respiratory allergy.
先前,接触过敏原二硝基氯苯(DNCB)被鉴定为 BALB/c 小鼠通过吸入致敏的变应原;此外,DNCB 诱导经皮致敏的倾向于 Th1 的 Wistar 大鼠在单次吸入挑战后在喉部发生淋巴细胞浸润。在本研究中,使用与单次挑战研究相同的方案研究了 DNCB 的重复吸入暴露:雌性 Wistar 大鼠用 DNCB 经皮致敏,随后每周两次通过吸入暴露于 7 或 15 mg/m(3) DNCB 两次,持续 4 周。未观察到与过敏相关的呼吸暂停性呼吸。在血清中发现了 DNCB 特异性 IgG 抗体,并且在鼻组织和喉部中发现了主要是淋巴细胞的炎症。在没有先前皮肤接触的情况下通过吸入重复暴露的动物中观察到了类似的效果,表明通过吸入致敏。这种炎症可能是上呼吸道对过敏性肺炎/变应性细支气管炎的类似物。应该研究长期暴露时气道炎症的可能进展,以支持或否定与呼吸道过敏相关的接触性和呼吸道变应原之间的区分。